Business Context and Reporting Period
This Form 8-K is filed by iSpecimen Inc. (ISPC) on March 13, 2026. The report addresses the status of the Company's 2025 Annual Meeting of Stockholders, originally scheduled for December 31, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events regarding the Annual Meeting.
Material Changes and Events
- Meeting Adjournments: The 2025 Annual Meeting was adjourned on December 31, 2025, due to a lack of quorum.
- Reconvened Meetings: The meeting was reconvened on January 23, 2026, February 13, 2026, and March 13, 2026. A quorum was not present at any of these reconvened sessions, resulting in further adjournments.
- Proposed Resumption: The Company intends to reconvene the Annual Meeting on April 10, 2026, at 9:00 a.m. Eastern Time.
- Voting Proposals: No changes have been made to the proposals described in the Proxy Statement filed on November 21, 2025.
- Record Date: The record date for stockholders entitled to vote remains November 3, 2025.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on operations, or specific risk factors beyond the immediate contingency of failing to achieve a quorum for the Annual Meeting. The primary contingency is the continued inability to hold the meeting, which prevents the voting on the proposals outlined in the November 2025 Proxy Statement.
Key Facts for Investor Verification
- Verify the specific proposals listed in the Proxy Statement filed on November 21, 2025, which remain pending due to the lack of quorum.
- Confirm the attendance and voting results of the reconvened Annual Meeting scheduled for April 10, 2026.
- Review the Company's stockholder communication efforts to understand why a quorum has not been achieved across four separate meeting dates.